Biotech

All Articles

Lykos will definitely inquire FDA to reconsider its choice observing being rejected of MDMA treatment for post-traumatic stress disorder

.Following a poor presenting for Lykos Therapies' MDMA candidate for trauma at a recent FDA consulta...

AN 2 halves head count, quits stage 3 trial after information disappoint

.AN2 Rehabs is reassessing its organization in reaction to poor midphase records, promising to give ...

Merck pays out $700M for bispecific, spying autoimmune opening and also opportunity to test Amgen in cancer cells

.Merck &amp Co. is actually paying for $700 thousand ahead of time to test Amgen in a blood cancer m...

Gilead pays for J&ampJ $320M to exit licensing deal for seladelpar

.With Gilead Sciences about to an FDA selection for its own liver illness medicine seladelpar, the f...

' All hands on deck' at Lilly as peers target weight problems market

.CEO David Ricks may view the companies setting up outdoors tents at basecamp behind Eli Lilly in a ...

Entero laying off workers, abandoning workplace and also pausing R&ampD

.Bed Liquidators has turned Entero Rehabs white colored as a slab. The financial institution ordered...

Exelixis falls ADC after determining it's no suit for Tivdak

.Exelixis is surrendering on its tissue aspect (TF)- targeting antibody-drug conjugate after conclud...

Relay loses interest in SHP2 prevention after Genentech leaves behind

.3 weeks after Roche's Genentech system bowed out an SHP2 prevention pact, Relay Rehab has actually ...

Stoke's Dravet syndrome med released of predisposed scientific hold

.Stoke Rehabs' Dravet disorder medicine has been without a partial grip, clearing the method for the...

Fierce Biotech's Gabrielle Masson presents Strong 15 at NYSE

.Tough Biotech Associate Editor Gabrielle Masson provided the 2024 class of Brutal 15 winners on the...